Alexander Natz | Secretary General
European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Alexander Natz is the Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (www.eucope.org) in Brussels and advises innovative pharmaceutical and biotech companies, including start-ups, in regulatory and pricing & reimbursement matters from the EU law and German law perspective.
From 2008 to 2013, he was Head of the Brussels Office of Bundesverband der Pharmazeutischen Industrie e.V. (BPI). Before, he has been a lawyer at Sträter Law Firm in Germany with a special focus on managed entry agreements and licensing of pharmaceuticals. Dr. Natz has also worked in the field of competition law with the European Commission and in the pharmaceutical industry. As a research assistant at Duke University (USA) he has dealt with international pharmaceutical law. His doctorate was supervised by the former judge at the European Court of Justice, Prof. Dr. Dr. Ulrich Everling.

Appearances:



Conference Day 1 - Tuesday 31st March 2020 @ 12:00

Technology and Strategy Roundtables will run from 12:00-12:45 with 15 minutes for a quick summary from each table at the front of the room. These will take place in the conference rooms: look for you

Technology and Strategy Roundtables will run from 12:00-12:45 with 15 minutes for a quick summary from each table at the front of the room. These will take place in the conference rooms: look for your table number to participate.

18. Ensuring ATMP access to patients

Conference Day 1 - Tuesday 31st March 2020 @ 17:00

Panel discussion: Finding the right framework for reimbursement and market access for cell and gene therapies

  • Updates on current EU pricing and contracts for Kymriah, Yescarta and Luxturna
  • Structured reimbursement system for hospital-based treatments in Europe: how is this working so far in 2020?
  • How should be looking at transformative therapy pricing in the next 5 years?
  • What is possible for statutory health insurance framework in the EU?
last published: 05/Mar/20 17:05 GMT

back to speakers